Mengis Capital Management, Inc. Viatris Inc Transaction History
Mengis Capital Management, Inc.
- $479 Million
- Q4 2024
A detailed history of Mengis Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 34,862 shares of VTRS stock, worth $331,189. This represents 0.09% of its overall portfolio holdings.
Number of Shares
34,862
Previous 34,899
0.11%
Holding current value
$331,189
Previous $405,000
7.16%
% of portfolio
0.09%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,141Shares Held
988MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$880 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$606 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$594 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$557 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...